相关实验视频
Updated: Jul 21, 2025

10:37
Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
9.6K
疼痛中的IGF/IGF-1R信号通路:一个有前途的治疗点
Lulin Ma1,2,3, Wenjing Zhao1,2,3, Shiqian Huang1,2,3
1Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
International journal of biological sciences
|July 27, 2023
概括
胰岛素样生长因子 (IGF) /IGF-1受体 (IGF-1R) 途径是新型止痛药的有希望的标. 针对这种途径可能通过调节神经元刺激和炎症来提供阿片类药物的替代品.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 疼痛研究 疼痛研究
背景情况:
- 疼痛管理仍然是医学的重大挑战,尽管有相当大的副作用,阿片类药物是主要的治疗方法.
- 迫切需要开发新的,有效的止痛药.
- 胰岛素类生长因子 (IGF) /IGF-1受体 (IGF-1R) 信号通路已与疼痛的发展和进展有关.
研究的目的:
- 审查和讨论针对IGF/IGF-1R信号通路来治疗疼痛的治疗潜力.
- 总结IGF/IGF-1R影响疼痛的机制,包括对神经元刺激性,神经炎症,质细胞和亡的影响.
主要方法:
- 文献综述和现有关于IGF/IGF-1R通路的疼痛研究的综合.
- 对研究IGF/IGF-1R在疼痛机制中的作用的分析.
主要成果:
- IGF/IGF-1R通路显著影响疼痛的发展和进展.
- 这种途径的调节显示出对疼痛的明显影响.
- IGF/IGF-1R通过调节神经元刺激性,神经炎症,质细胞活性和亡来影响疼痛.
结论:
- IGF/IGF-1R信号通路代表了新型疼痛治疗的有希望的治疗标.
- 需要进一步的研究才能充分阐明它在疼痛中的作用背后的机制.
- 准IGF/IGF-1R通路可能会导致非阿片类止痛药的开发.
相关概念视频
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
Analgesia and Pain Management
660
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
660
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
Nociception
28.0K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
28.0K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K

